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INTRODUCTION:  Primary  extra  osseous  osteogenic  sarcomas  have  been  reported  in  many  tissues  of  the
body  but  their  occurrence  in the  breast  is  extremely  rare.  It  can arise  as  a result  of  osseous  metaplasia  in
a pre-existing  benign  or  malignant  neoplasm  of the  breast.
CASE  PRESENTATION:  A  24  year-old  young  lady  was  diagnosed  to  have  mass  in  right  breast.Tru  cut  biopsy
showed  it was  malignant  phyllodes  tumour.  There  was no  distant  metastasis  or any  axillary  lymph  nodes
palpable.  Simple  mastectomy  was  done.  The  histology  report  of  biopsy  showed  a  malignant  phyllodes
with  chondrosarcomatous  differentiation  an myxoid  changes.  She  was  given  6  cycles  of chemotherapy.
There was  recurrence  after  6 months  of  surgery.  Then  radical  mastectomy  with  latissimus  dorsi  muscu-
locutaneous  ﬂap was  used  to  cover  the  anterior  chest  wall  defect.  Sections  from  the  mastectomy  specimendjuvant chemotherapy
alignant phyllodes
conﬁrmed  the  diagnosis  of  chondroblastic  osteosarcoma.  Axillary  nodes  free  of tumour  cells.
Now the  patient  again  came  with  recurrence  after  5 months,  and  disseminate  subcutaneous  nodules.
CONCLUSION:  A diagnosis  of  chondroblastic  osteosarcoma  of the  breast  was  made  based  on  histology
report  and  after  excluding  any  osteogenic  sarcoma  arising  from  underlying  ribs  and  sternum.  It  is a  very
rare  disease  with  only  few  case  reports  in  literature.
©  2016  The  Authors.  Published  by  Elsevier  Ltd  on  behalf  of  IJS Publishing  Group  Ltd.  This is  an  open
he  CCaccess  article  under  t
. Introduction
Extra skeletal osteosarcomas are uncommon neoplasms repre-
enting less than 1% of soft tissue sarcomas. Mammary sarcomas
re rarer, accounting for less than 1% of all primary breast malig-
ant tumours. In this group, primary osteosarcomas are one of the
east common sarcomas of the breast [1,2]. Most cases have been
eported in the literature as case reports except Silver et al. who
eported a retrospective analysis of 50 cases [3]. With less than a
undred cases of primary mammary osteosarcoma reported in the
iterature [4,5].
Extra-skeletal osteosarcoma has been documented in many tis-
ues of the body including the thyroid gland, kidney, bladder, colon,
eart, testis, penis, gall bladder and the cerebellum. When it occurs
n the breast, it originates either from normal breast tissue de novo,
r as metaplastic differentiation of a primary benign or malignant
reast lesion. Osteogenic sarcomas of the breast either arising pri-
arily in the breast or as secondary deposits from primary bone
arcomas occur in very rare cases [6].
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2. Case report
A 24 year-old young lady came to Surgery OPD in PGIMER & Dr.
RML  Hospital, New Delhi with a 5*4 cm lump in right breast from 3
months (Figs. 4 and 5). TRU cut biopsy showed it was  malignant
phyllodes tumour. There was no distant metastasis or any axil-
lary lymph nodes palpable. Simple mastectomy was done and the
specimen was sent for histopathological examination.
The histology report of showed a malignant phyllodes with
chondrosarcomatous differentiation there were malignant spin-
dle cells and osteoclasts like multi-nucleated tumour giant cells.
Cartilaginous differentiation with osteoid production were also
seen (Figs. 1–3). Resected margins were tumour free. IHC showed
vimentin positive in sarcomatous areas and CD 10 positive in spin-
dle cells. She was given 6 cycles of chemotherapy with Doxorubicin,
Ifosfamide and mesna by the oncology department.
There was recurrence at the site of surgery after 6 months of
surgery, while she was on chemotherapy. Then radical mastectomy
with latissimus dorsi musculocutaneous ﬂap was  used to cover the
anterior chest wall defect. Sections from the mastectomy specimen
conﬁrmed the diagnosis of chondroblastic osteosarcoma with spin-
dle cells with marked nuclear pleomorphism, many tumour giant
cells, osteoid productions and focal chondroblastic differentiation
as in (Figs. 1–3). Axillary nodes were free of tumour cells.
up Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Figs. 1–2. Showing malignant spindle cells and osteoclast like multi nucleated tumour giant cells. (20×).
Fig. 3. Showing cartilaginous differentiation with osteoid production.
3
a
6Fig. 4. An axillary mass, recurrent right breast mass, an epigastric mass.
. Follow upNow the patient again came with recurrence after 5 months,
nd disseminate subcutaneous nodules over upper abdomen of size
*6 cm,  back, scalp, neck and both forearm. There is a hard lump inFig. 5. Donor site of latissimus dorsi ﬂap with multiple subcutaneous nodules over
her  back.
her right axilla, with restricted mobility of the right upper limb
(Figs. 4 and 5). CECT chest showed left sided mediastinal mass and
a necrotic axillary node likely to be malignant. USG abdomen was
within normal limits.
4. Discussion
Malignant phyllodes tumour is a large, unilateral, painless,
rapidly progressing lump with boss-elated surface. Median age
of 45 years, axillary lymph nodes present in 20% cases. Risk of
malignancy in phyllodes tumour is only 5%. FNAC shows dimorphic
stromal and epithelial elements. Core needle shows hyper-cellular
stromal components and IHC positive for CD10 and NOS (nitric
oxide synthase).
Pure sarcomas of the breast are uncommon, accounting for less
than 1% of primary breast malignant tumours [7,8]. More common
breast sarcomas include ﬁbrosarcomas, malignant ﬁbrous histio-
cytoma, angiosarcoma, and liposarcoma [9]. Primary mammary
osteosarcoma of the breast represents 12.5% of breast sarcomas [7].
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umours with the following criteria are considered ‘pure osteosar-
oma’: absence of bone origin, presence of osteoid or bony matrix,
bsence of an epithelial differentiation, and absence of a benign
umour.
Mammary osteosarcoma predominates in middle-aged and
lder women. Most often, they arise as de novo conditions without
redisposing factors especially after radiation therapy [3]. All cases
eported in literature had unilateral disease [7].
Clinical features, mammographic and macroscopic ﬁndings are
ot speciﬁc [11]. Mammographically, these tumours are usu-
lly dense and well-circumscribed with focal or extensive coarse
alciﬁcations [7,12]. Microscopic ﬁndings of primary mammary
steosarcoma are similar to skeletal and other extra-skeletal
steosarcomas. Considerable diversity in morphological appear-
nce has been reported with variants like ﬁbroblastic, osteoblastic,
steoclastic, and chondroblastic; a variable amount of osteoid
issue and bone are present in all [7]. Chondrosarcomatous differ-
ntiation is unusual as reported in our case [3,11].
In localised forms, the treatment is based on surgical exci-
ion with clear margins. Lymph node metastases are exceptional
o that lymphadenectomy is not indicated. There is controversy
egarding the use of chemotherapy. For some authors, it is not
ecommended especially in localised and well-resected low-grade
umours. Regarding metastasising tumours, treatment is based
ainly on chemotherapy using conventional drugs for osteosar-
oma (doxorubicin, ifosfamide, cisplatin, methotrexate) [13,14].
The prognosis is poor and the ﬁve-year survival is 38%. Recur-
ences are less frequent in patients treated with mastectomy than
hose treated with local excision. Metastases occur mainly in the
ung; there is no axillary node involvement in almost all cases [10].
ases of death occurring a few months after the diagnosis have been
eported [1,8].
. Conclusion
Chondroblastic osteosarcoma of breast is a very rare malig-
ancy where a deﬁnitive diagnosis is established after a histology
athological examination and immunochemistry staining of the
pecimen. Surgical excision with clear surgical margins remains
he cornerstone of treatment. There is limited literature to support
he role of local radiotherapy for control of tumour recurrences in
atients with primary breast osteosarcoma is still not established.
ake away lesson
Chondroblastic Osteosarcoma of breast Is a highly aggressive
umor with poor prognosis and even after aggressive surgery and
djuvant chemotherapy.onﬂict of interest
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